Treating Sexual Desire Disorders with Flibanserin

Abstract

The invention relates to the use of flibanserin, or a pharmaceutically acceptable acid addition salt thereof, for the treatment of disorders of sexual desire.

1 . A method of treating decreased sexual desire in a patient, comprising administering a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof to the patient to treat decreased sexual desire. 
     
     
         2 . The method according to  claim 1 , wherein the patient is female. 
     
     
         3 . The method according to  claim 1 , wherein the patient is male. 
     
     
         4 . The method according to  claim 1 , wherein the amount administered is between about 0.1 mg and 400 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         5 . The method according to  claim 1 , wherein the amount administered is between about 1 mg and 300 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         6 . The method according to  claim 1 , wherein the amount administered is in a dosage unit containing between about 0.01 mg and 100 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         7 . The method according to  claim 1 , wherein the amount administered is in a dosage unit containing between about 0.1 mg and 50 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         8 . A method of treating absent sexual desire in a patient, comprising administering a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof to the patient to treat decreased sexual desire. 
     
     
         9 . The method according to  claim 8 , wherein the patient is female. 
     
     
         10 . The method according to  claim 8 , wherein the patient is male. 
     
     
         11 . The method according to  claim 8 , wherein the amount administered is between about 2 mg and 200 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         12 . The method according to  claim 8 , wherein the amount administered is between about 0.1 mg and 100 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         13 . The method according to  claim 8 , wherein the amount administered is in a dosage unit containing about 150 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         14 . A method of treating inhibited sexual desire in a patient, comprising administering a therapeutically effective amount of flibanserin or a pharmaceutically acceptable acid addition salt thereof to the patient to treat decreased sexual desire. 
     
     
         15 . The method according to  claim 14 , wherein the patient is female. 
     
     
         16 . The method according to  claim 14 , wherein the patient is male. 
     
     
         17 . The method according to  claim 14 , wherein the amount administered is between about 0.1 mg and 400 mg per day of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         18 . The method according to  claim 14 , wherein the amount administered is in a dosage unit containing about 100 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         19 . The method according to  claim 14 , wherein the amount administered is in a dosage unit containing about 80 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof. 
     
     
         20 . The method according to  claim 14 , wherein the amount administered is in a dosage unit containing about 50 mg of flibanserin or a pharmaceutically acceptable acid addition salt thereof.